XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 7 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kamunting Street Capital Management, L.P. | 1,500 | $1,508,000 | 1.72% |
| Context Capital Management, LLC | 3,250,000 | $3,202,000 | 1.24% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 0.89% |
| 683 Capital Management, LLC | 10,000,000 | $10,050,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,000,000 | $17,732,000 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 1,500,000 | $1,496,000 | 0.37% |
| Hound Partners | 2,500,000 | $2,476,000 | 0.22% |
| DeepCurrents Investment Group LLC | 6,000,000 | $6,117,000 | 0.22% |
| WHITEBOX ADVISORS LLC | 4,000,000 | $3,941,000 | 0.22% |
| Antara Capital LP | 1,500,000 | $1,485,000 | 0.16% |